Publications

2024

339.
Bojmar L., Zambirinis C. P., Hernandez J. M. et al. (2024) Nature Medicine. 30, 8, p. 2170-2180  Abstract [All authors]
338.
Lim L. Q. J., Adler L., Hajaj E. et al. (2024) Nature metabolism. 6, 7, p. 1294-1309  Abstract [All authors]
337.
Lü Y. Q., Cho T., Mukherjee S. et al. (2024) Molecular Systems Biology. 20, 6, p. 719-740  Abstract [All authors]
336.
Böpple K., Oren Y., Henry W. S. et al. (2024) Cell Death and Disease. 15, 290.  Abstract [All authors]
335.
Abbas R., Hartmann O., Asiss D. T. et al. (2024) Apoptosis. 29, 7-8, p. 1145-1160  Abstract [All authors]
334.
Oren M. & Prives C. (2024) Cell. 187, 7, p. 1569-1573  Abstract

2023

333.
Hassin O., Sernik M., Seligman A. et al. (2023) Proceedings of the National Academy of Sciences of the United States of America. 120, 52, e231146012.  Abstract [All authors]
332.
Gershoni A., Hassin O., Nataraj N. B. et al. (2023) Molecular Oncology. 17, 12, p. 2675-2693  Abstract [All authors]
331.
Michael D., Feldmesser E., Gonen C. et al. (2023) FEBS Letters. 597, 9, p. 1233-1245  Abstract [All authors]
330.
Vitale I., Pietrocola F., Guilbaud E. et al. (2023) Cell Death and Differentiation. 30, 5, p. 1097-1154  Abstract [All authors]
329.
Venghateri J. B., Dassa B., Morgenstern D., Shreberk-Shaked M., Oren M. & Geiger B. (2023) Cell Death and Disease. 14, 4, 290.  Abstract
328.
Hassin O. & Oren M. (2023) Nature reviews. Drug discovery. 22, 2, p. 127-144  Abstract
327.
Aylon Y., Furth N., Mallel G. et al. (2023) Nature Communications. 14, 1, 133.  Abstract [All authors]

2022

326.
Hassin O., Nataraj N. B., Shreberk-Shaked M. et al. (2022) Nature Communications. 13, 1, 2800.  Abstract [All authors]
325.
Aylon Y., Furth N., Mallel G. et al. (2022) Nature Communications. 13, 1, 7199.  Abstract [All authors]
324.
Tuval A., Brilon Y., Azogy H. et al. (2022) Haematologica. 107, 11, p. 2548-2561  Abstract [All authors]
323.
Noronha A., Belugali Nataraj N., Sang Lee J. et al. (2022) Cancer Discovery. 12, 11, p. 2666-2683  Abstract [All authors]
322.
Mukherjee S., Maddalena M., Lü Y. et al. (2022) Proceedings of the National Academy of Sciences. 119, 17, e211964411.  Abstract [All authors]

2021

321.
Maddalena M., Mallel G., Nataraj N. B. et al. (2021) Proceedings of the National Academy of Sciences. 118, 23, e202563111.  Abstract [All authors]
320.
Ghosh S., Nataraj N. B., Noronha A. et al. (2021) Cell Reports. 35, 8, 109181.  Abstract [All authors]

2020

319.
Shreberk-Shaked M., Dassa B., Sinha S. et al. (2020) Cancer Research. 80, 19, p. 4145-4157  Abstract [All authors]
318.
Benor G., Fuks G., Chin S. et al. (2020) Molecular Oncology. 14, 8, p. 1640-1652  Abstract [All authors]
317.
Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061.e18  Abstract [All authors]
316.
Kadosh E., Snir-Alkalay I., Venkatachalam A. et al. (2020) Nature. 7827, p. 133-+  Abstract [All authors]

2019

315.
Oren M. (2019) Journal of Molecular Cell Biology. 11, 7, p. 539-543  Abstract
314.
Shreberk-Shaked M. & Oren M. (2019) Molecular Oncology. 13, 6, p. 1335-1341  Abstract
313.
Hooda J., Novak M., Salomon M. P. et al. (2019) Cancer Research. 79, 4, p. 760-772  Abstract [All authors]

2018

312.
Furth N., Pateras I. S., Rotkopf R. et al. (2018) Life science alliance. 1, 5, 201800171.  Abstract [All authors]
311.
Minzel W., Venkatachalam A., Fink A. et al. (2018) Cell. 175, 1, p. 171-185  Abstract [All authors]
310.
Kotler E., Segal E. & Oren M. (2018) Molecular & cellular oncology. 5, 6, 1511207.  Abstract
309.
Kotler E., Shani O., Goldfeld G. et al. (2018) Molecular Cell. 71, 1, p. 178-190  Abstract [All authors]
308.
Jethwa A., Slabicki M., Huellein J. et al. (2018) Blood. 131, 25, p. 2789-2802  Abstract [All authors]
307.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
306.
Ghannam-Shahbari D., Jacob E., Kakun R. R. et al. (2018) Oncogene. 37, 17, p. 2213-2224  Abstract [All authors]
305.
Solomon H., Dinowitz N., Pateras I. S. et al. (2018) Oncogene. 37, 12, p. 1669-1684  Abstract [All authors]
304.
Galluzzi L., Vitale I., Aaronson S. A. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract [All authors]
303.
Furth N., Aylon Y. & Oren M. (2018) Cell Death and Differentiation. 25, p. 81-92  Abstract

2017

302.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 1268112699  Abstract [All authors]
301.
Spolverini A., Fuchs G., Bublik D. R. & Oren M. (2017) Oncogene. 36, 42, p. 5819-5828  Abstract
300.
Aylon Y. & Oren M. (2017) Cancer Cell. 32, 4, p. 397-399  Abstract
299.
Tovy A., Spiro A., McCarthy R. et al. (2017) GENES & DEVELOPMENT. 31, 10, p. 959-972  Abstract
[All authors]
298.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
297.
Bublik D. R., Bursac S., Sheffer M. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505  Abstract [All authors]
296.
Isaac R., Goldstein I., Furth N. et al. (2017) Cell Death and Differentiation. 24, 1, p. 132-143  Abstract [All authors]

2016

295.
Simerzin A., Zorde-Khvalevsky E., Rivkin M. et al. (2016) Hepatology. 64, 5, p. 1623-1636  Abstract [All authors]
294.
Aylon Y. & Oren M. (2016) Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-2255  Abstract
293.
Yaeger R., Shah M. A., Miller V. A. et al. (2016) Gastroenterology. 151, 2, p. 278-287.e6  Abstract [All authors]
292.
Oren M. & Kotler E. (2016) Nature Cell Biology. 18, 8, p. 833-835  Abstract
291.
Stock K., Estrada M. F., Vidic S. et al. (2016) Scientific Reports. 6, 28951.  Abstract [All authors]
290.
Aylon Y. & Oren M. (2016) Cold Spring Harbor perspectives in medicine. 6, 10, a026328.  Abstract
289.
Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016) Seminars in Cancer Biology. 37-38, p. 36-50  Abstract
288.
Barbier M., Jaensch S., Cornelissen F. et al. (2016) PLoS ONE. 11, 6, e0156942.  Abstract [All authors]
287.
Aylon Y., Gershoni A., Rotkopf R. et al. (2016) GENES & DEVELOPMENT. 30, 7, p. 786-797  Abstract [All authors]
286.
Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016) Oncotarget. 7, 11, p. 11817-11837  Abstract
285.
Tarcic O., Pateras I. S., Cooks T. et al. (2016) Cell Reports. 14, 6, p. 1462-1476  Abstract [All authors]
284.
Hoffman Y., Bublik D. R., Ugalde A. P., Elkon R., Biniashvili T., Agami R., Oren M. & Pilpel Y. (2016) PLoS Genetics. 12, 2, e1005879.  Abstract
283.
Oren M., Tal P. & Rotter V. (2016) AGING-US. 8, 6, p. 1159-1160  Abstract

2015

282.
Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015) Cell Death and Differentiation. 22, 11, p. 1764-1774  Abstract
281.
Blume C. J., Hotz-Wagenblatt A., Hüllein J. et al. (2015) Leukemia. 29, 10, p. 2015-2023  Abstract [All authors]
280.
Harel S., Ben-Moshe N., Aylon Y. et al. (2015) Cell Death and Differentiation. 22, p. 1328-1340  Abstract [All authors]
279.
Oren M., Damalas A., Gottlieb T. et al. (2015) Biochemical Pharmacology. 96, 4, p. 369 12280.  Abstract [All authors]
278.
Pribluda A., Elyada E., Wiener Z. et al. (2015) Cancer Cell. 27, 6, p. 877-878  Abstract
[All authors]
277.
Fuchs G., Voichek Y., Rabani M., Benjamin S., Gilad S., Amit I. & Oren M. (2015) Nature protocols. 10, 4, p. 605-618  Abstract
276.
Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015) Genes and Development. 29, p. 2325-2330  Abstract

2014

275.
Lasry A., Aran D., Zinger A. et al. (2014) Cytokine. 70, 1, p. 22-22  Abstract
[All authors]
274.
Fuchs G., Hollander D., Voichek Y., Ast G. & Oren M. (2014) Genome Research. 24, 10, p. 1572-1583  Abstract
273.
Cooks T., Harris C. & Oren M. (2014) Carcinogenesis. 35, 8, p. 1680-1690  Abstract
272.
Golomb L., Volarevic S. & Oren M. (2014) FEBS Letters. 588, 16, p. 2571-2579  Abstract
271.
Fuchs G. & Oren M. (2014) Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 1839, 8, p. 694-701  Abstract
270.
Weilbacher A., Gutekunst M., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2014) Cell Death & Disease. 5, 7, e1318.  Abstract
269.
Oren M. (2014) European Journal of Cancer. 50, p. VII  Abstract
268.
Hoffman Y., Pilpel Y. & Oren M. (2014) Journal of Molecular Cell Biology. 6, 3, p. 192-197  Abstract
267.
Aylon Y., Sarver A., Tovy A., Ainbinder E. & Oren M. (2014) Cell Death and Differentiation. 21, 4, p. 624-633  Abstract
266.
Hoffman Y., Bublik D. R., Pilpel Y. & Oren M. (2014) Cell Death and Differentiation. 21, 2, p. 302-309  Abstract
265.
Shtivelman E., Davies M. A., Hwu P., Yang J., Lotem M., Oren M., Flaherty K. T. & Fisher D. E. (2014) Oncotarget. 5, 7, p. 1701-1752  Abstract
264.
Fuchs G., Voichek Y., Benjamin S., Gilad S., Amit I. & Oren M. (2014) GENOME BIOLOGY. 15, 5, p. R69  Abstract
263.
Weingarten-Gabbay S., Khan D., Liberman N., Yoffe Y., Bialik S., Das S., Oren M. & Kimchi A. (2014) Oncogene. 33, 5, p. 611-618  Abstract

2013

262.
Fausti F., Di Agostino A. S., Cioce M. et al. (2013) Cell Death and Differentiation. 20, 11, p. 1498-1509  Abstract
[All authors]
261.
Golomb L. & Oren M. (2013) Cell Death and Differentiation. 20, 11, p. 1442-1443  Abstract
260.
Pribluda A., Elyada E., Wiener Z. et al. (2013) Cancer Cell. 24, 2, p. 242-256  Abstract [All authors]
259.
Cooks T., Pateras I. S., Tarcic O. et al. (2013) Cancer Cell. 23, 5, p. 634-646  Abstract [All authors]
258.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013)  Abstract
257.
Hoffman Y., Dahary D., Bublik D. R., Oren M. & Pilpel Y. (2013) Bioinformatics. 29, 7, p. 894-902  Abstract
256.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Bedke J., Kruck S., Oren M., Aulitzky W. E. & Van Der Kuip H. (2013) Cancer Research. 73, 5, p. 1460-1469  Abstract
255.
Suzuki H., Yabuta N., Okada N., Torigata K., Aylon Y., Oren M. & Nojima H. (2013) Journal of Cell Science. 126, 19, p. 4358-4368  Abstract
254.
Shema E., Nikolov M., Haj-Yahya M. et al. (2013) Cell Reports. 4, 3, p. 601-608  Abstract [All authors]

2012

253.
Bursać S., Brdovčak M. C., Pfannkuchen M. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America. 109, 50, p. 20467-20472  Abstract [All authors]
252.
Hornung G., Bar-Ziv R., Rosin D., Tokuriki N., Tawfik D., Oren M. & Barkai N. (2012) Genome Research. 22, 12, p. 2409-2417  Abstract
251.
Haj-Yahya M., Eltarteer N., Ohayon S., Shema E., Kotler E., Oren M. & Brik A. (2012) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 51, 46, p. 11535-11539  Abstract
250.
Schmid J. O., Dong M., Haubeiss S. et al. (2012) Cancer Research. 72, 22, p. 5824-5832  Abstract
[All authors]
249.
Fuchs G., Shema E., Vesterman R. et al. (2012) Molecular Cell. 46, 5, p. 662-673  Abstract [All authors]
248.
Hornung G., Oren M. & Barkai N. (2012) Molecular Cell. 46, 3, p. 362-368  Abstract
247.
Bublik D. R. & Oren M. (2012) EMBO Reports. 13, 4, p. 282-283  Abstract
246.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
245.
Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K. & Oren M. (2012) Cell Death and Differentiation. 19, 1, p. 180-183  Abstract
244.
Golomb L., Bublik D. R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S. & Oren M. (2012) Molecular Cell. 45, 2, p. 222-232  Abstract

2011

243.
Furth N. & Oren M. (2011) Cell Cycle. 10, 18, p. 3054-3055  Abstract
242.
Shiloh Y., Shema E., Moyal L. & Oren M. (2011) FEBS Letters. 585, 18, p. 2795-2802  Abstract
241.
Golomb L. & Oren M. (2011) Cancer Cell. 20, 3, p. 283-284  Abstract
240.
Aylon Y. & Oren M. (2011) Molecular Oncology. 5, 4, p. 315-323  Abstract
239.
Tarocchi M., Hannivoort R., Hoshida Y. et al. (2011) Hepatology. 54, 2, p. 522-531  Abstract
[All authors]
238.
Shema E., Oren M. & Minsky N. (2011) Methods. 54, 3, p. 326-330  Abstract
237.
Dell'Orso S., Fontemaggi G., Stambolsky P. et al. (2011) Omics-A Journal Of Integrative Biology. 15, 5, p. 305-312  Abstract [All authors]
236.
Shema E., Kim J., Roeder R. G. & Oren M. (2011) Molecular Cell. 42, 4, p. 477-488  Abstract
235.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
234.
Aylon Y. & Oren M. (2011) Current opinion in genetics & development. 21, 1, p. 86-92  Abstract
233.
Elyada E., Pribluda A., Goldstein R. E. et al. (2011) Nature. 470, 7334, p. 409-413  Abstract [All authors]
232.
Goldstein I., Marcel V., Olivier M., Oren M., Rotter V. & Hainaut P. (2011) Cancer Gene Therapy. 18, 1, p. 2-11  Abstract
231.
Gutekunst M., Oren M., Weilbacher A., Dengler M. A., Markwardt C., Thomale J., Aulitzky W. E. & van der Kuip H. (2011) PLoS ONE. 6, 4, e19198.  Abstract
230.
Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M. & Nojima H. (2011) Journal of Cell Science. 124, 1, p. 57-67  Abstract

2010

229.
Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R. N., Neeman M. & Oren M. (2010) Cancer Research. 70, 23, p. 9650-9658  Abstract
228.
Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X. & Oren M. (2010) GENES & DEVELOPMENT. 24, 21, p. 2420-2429  Abstract
227.
Nili E. L., Field Y., Lubling Y., Widom J., Oren M. & Segal E. (2010) Genome Research. 20, 10, p. 1361-1368  Abstract
226.
Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z. & Oren M. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 43, p. 18511-18516  Abstract
225.
Shalgi R., Pilpel Y. & Oren M. (2010) Trends in Genetics. 26, 6, p. 253-259  Abstract
224.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 5, p. 523  Abstract [All authors]
223.
Schilling T., Kairat A., Melino G., Krammer P. H., Stremmel W., Oren M. & Müller M. (2010) Biochemical and Biophysical Research Communications. 394, 3, p. 817-823  Abstract
222.
Oren M. & Cooks T. (2010) Cell Cycle. 9, 6, p. 1025-1030  Abstract
221.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 3, p. 273-285  Abstract [All authors]
220.
Oren M. & Rotter V. (2010) Cold Spring Harbor perspectives in biology. 2, 2, p. a001107  Abstract
219.
Bar J., Moskovits N. & Oren M. (2010) SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 21, 1, p. 47-54  Abstract
218.
Christoffersen N. R., Shalgi R., Frankel L. B. et al. (2010) Cell Death and Differentiation. 17, 2, p. 236-245  Abstract [All authors]

2009

217.
Skorta I., Oren M., Markwardt C., Gutekunst M., Aulitzky W. E. & Van Der Kuip H. (2009) Cancer Research. 69, 24, p. 9337-9345  Abstract
216.
Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H. & Oren M. (2009) Oncogene. 28, 50, p. 4469-4479  Abstract
215.
Levine A. J. & Oren M. (2009) Nature Reviews Cancer. 9, 10, p. 749-758  Abstract
214.
Schilling T., Schleithoff E. S., Kairat A., Melino G., Stremmel W., Oren M., Krammer P. H. & Müller M. (2009) Biochemical and Biophysical Research Communications. 387, 2, p. 399-404  Abstract
213.
Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
Shalgi R., Brosh R., Oren M., Pilpel Y. & Rotter V. (2009) AGING-US. 1, 9, p. 762-770  Abstract
212.
Bar J., Feniger-Barish R., Lukashchuk N. et al. (2009) Oncogene. 28, 6, p. 933-936  Abstract [All authors]
211.
Pirngruber J., Shchebet A., Schreiber L. et al. (2009) EMBO Reports. 10, 8, p. 894-900  Abstract [All authors]
210.
Lavelin I., Beer A., Kam Z., Rotter V., Oren M., Navon A. & Geiger B. (2009) PLoS ONE. 4, 12, e8503.  Abstract

2008

209.
Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M. B. & Oren M. (2008) Molecular Cell. 32, 2, p. 180-189  Abstract
208.
Shema E., Tirosh I., Aylon Y. et al. (2008) GENES & DEVELOPMENT. 22, 19, p. 2664-2676  Abstract [All authors]
207.
Finkin S., Aylon Y., Anzi S., Oren M. & Shaulian E. (2008) Oncogene. 27, 32, p. 4411-4421  Abstract
206.
Bossi G., Marampon F., Maor-Aloni R., Zani B., Rotter V., Oren M., Strano S., Blandino G. & Sacchi A. (2008) Cell Cycle. 7, 12, p. 1870-1879  Abstract
205.
Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M. & Tanaka N. (2008) Proceedings of the National Academy of Sciences of the United States of America. 105, 12, p. 4838-4843  Abstract
204.
Minsky N., Shema E., Field Y., Schuster M., Segal E. & Oren M. (2008) Nature Cell Biology. 10, 4, p. 483-488  Abstract
203.
Brosh R., Shalgi R., Liran A. et al. (2008) Molecular Systems Biology. 4, 229.  Abstract
[All authors]

2007

202.
Lantner F., Starlets D., Gore Y. et al. (2007) Blood. 110, 13, p. 4303-4311  Abstract
[All authors]
201.
Raver-Shapira N. & Oren M. (2007) Cell Cycle. 6, 21, p. 2656-2661  Abstract
200.
Lu X., Ma O., Nguyen T. A., Jones S. N., Oren M. & Donehower L. A. (2007) Cancer Cell. 12, 4, p. 342-354  Abstract
199.
Reef S., Shifman O., Oren M. & Kimchi A. (2007) Oncogene. 26, 46, p. 6677-6683  Abstract
198.
Aylon Y. & Oren M. (2007) Cell. 130, 4, p. 597-600  Abstract
197.
Shalgi R., Lieber D., Oren M. & Pilpel Y. (2007) PLoS Computational Biology. 3, 7, p. 1291-1304  Abstract
196.
Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z. & Oren M. (2007) Molecular Cell. 26, 5, p. 731-743  Abstract
195.
Weisz L., Oren M. & Rotter V. (2007) Oncogene. 26, 15, p. 2202-2211  Abstract
194.
Weisz L., Damalas A., Liontos M. et al. (2007) Cancer Research. 67, 6, p. 2396-2401  Abstract [All authors]
193.
Oren M. & Bartek J. (2007) Cell. 128, 5, p. 826-828  Abstract
192.
Shmueli A. & Oren M. (2007) Molecular Cell. 25, 6, p. 794-796  Abstract

2006

191.
Stambolsky P., Weisz L., Shats I., Klein Y. A., Goldfinger N., Oren M. & Rotter V. (2006) Cell Death and Differentiation. 13, 12, p. 2140-2149  Abstract
190.
Moskovits N., Kalinkovich A., Bar J., Lapidot T. & Oren M. (2006) Cancer Research. 66, 22, p. 10671-10676  Abstract
189.
Oren M. (2006) Ejc Supplements. 4, 12, p. 76-76  Abstract
188.
Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H. & Oren M. (2006) Genes and Development. 20, 19, p. 2687-2700  Abstract
187.
Rentsch C. A., Germann M., Wetterwald A. et al. (2006) European Urology Supplements. 5, 14, p. 790-790  Abstract
[All authors]
186.
Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S., Oren M. & Livneh Z. (2006) Molecular Cell. 22, 3, p. 407-413  Abstract
185.
Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M. & Kimchi A. (2006) Molecular Cell. 22, 4, p. 463-475  Abstract
184.
Kogan I., Goldfinger N., Milyavsky M. et al. (2006) Cancer Research. 66, 7, p. 3531-3540  Abstract
[All authors]
183.
Margalit O., Amram H., Amariglio N. et al. (2006) Blood. 107, 4, p. 1599-1607  Abstract [All authors]
182.
Zalcenstein A., Weisz L., Stambolsky P., Bar J., Rotter V. & Oren M. (2006) Oncogene. 25, 3, p. 359-369  Abstract

2005

181.
Bar J., Lukaschuk N., Zalcenstein A., Wilder S., Seger R. & Oren M. (2005) Cell Death and Differentiation. 12, 12, p. 1578-1587  Abstract
180.
Muller M., Schilling T., Sayan A. et al. (2005) Cell Death and Differentiation. 12, 12, p. 1564-1577  Abstract [All authors]
179.
Shmueli A. & Oren M. (2005) Cell. 121, 7, p. 963-965  Abstract
178.
Gressner O., Schilling T., Lorenz K. et al. (2005) EMBO Journal. 24, 13, p. 2458-2471  Abstract [All authors]
177.
Oberst A., Rossi M., Salornoni P., Pandolfi P., Oren M., Melino G. & Bernassola F. (2005) Biochemical and Biophysical Research Communications. 331, 3, p. 707-712  Abstract
176.
Hershko T., Chaussepied M., Oren M. & Ginsberg D. (2005) Cell Death and Differentiation. 12, 4, p. 377-383  Abstract
175.
Wohlbold L., van der Kuip d. K. H., Moehring A., Granot G., Oren M., Vornlocher H. & Aulitzky W. (2005) Leukemia. 19, 2, p. 290-292  Abstract
174.
Damalas A., Weis L., Nordgard S. et al. (2005) Breast Cancer Research. 7, p. S53-S53  Abstract
[All authors]

2004

173.
Minsky N. & Oren M. (2004) Molecular Cell. 16, 4, p. 631-639  Abstract
172.
Weisz L., Zalcenstein A., Stambolsky P., Cohen Y., Goldfinger N., Oren M. & Rotter V. (2004) Cancer Research. 64, 22, p. 8318-8327  Abstract
171.
Daniely Y., Liao G., Dixon D., Linnoila R. I., Lori A., Randell S. H., Oren M. & Jetten A. M. (2004) American Journal Of Physiology-Cell Physiology. 287, 1 56-1, p. C171-C181  Abstract
170.
Levina E., Oren M. & Ben-Ze'ev A. (2004) Oncogene. 23, 25, p. 4444-4453  Abstract
169.
Bar J., Cohen-Noyman E., Geiger B. & Oren M. (2004) Oncogene. 23, 12, p. 2128-2137  Abstract
168.
Fiucci G., Beaucourt S., Duflaut D. et al. (2004) Proceedings of the National Academy of Sciences of the United States of America. 101, 10, p. 3510-3515  Abstract
[All authors]
167.
Wang X., Taplick J., Geva N. & Oren M. (2004) FEBS Letters. 561, 1-3, p. 195-201  Abstract
166.
Shmueli A. & Oren M. (2004) Molecular Cell. 13, 1, p. 4-5  Abstract

2003

165.
Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
164.
Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 431-442  Abstract
163.
Wang X., Zalcenstein A. & Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 468-476  Abstract
162.
Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M. & Lavi S. (2003) Journal of Biological Chemistry. 278, 16, p. 14299-14305  Abstract
161.
Passer B., Nancy-Portebois V., Amzallag N. et al. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2284-2289  Abstract [All authors]
160.
Michael D. & Oren M. (2003) Seminars in Cancer Biology. 13, 1, p. 49-58  Abstract
159.
Nuclear factor-κB protects the liver against genotoxic stress and functions independently of p53
Lavon I., Pikarsky E., Gutkovich E., Goldberg I., Bar J., Oren M. & Ben-Neriah Y. (2003) Cancer Research. 63, 1, p. 25-30  Abstract

2002

158.
Blandert G., Zalle N., Daniely Y., Taplick J., Gray M. D. & Oren M. (2002) Journal of Biological Chemistry. 277, 52, p. 50934-50940  Abstract
157.
Oren M., DAMALAS A., GOTTLIEB T. et al. (2002) Annals of the New York Academy of Sciences. 973, 1, p. 374-383  Abstract
[All authors]
156.
Balass M., Kalef E., Maya R., Wilder S., Oren M. & Katchalski-Katzir E. (2002) Peptides. 23, 10, p. 1719-1725  Abstract
155.
Shtutman M., Zhurinsky J., Oren M., Levina E. & Ben-Ze'ev A. (2002) Cancer Research. 62, 20, p. 5947-5954  Abstract
154.
Goldberg Z., Vogt Sionov S. R., Berger M., Zwang Y., Perets R., Van Etten E. R., Oren M., Taya Y. & Haupt Y. (2002) EMBO Journal. 21, 14, p. 3715-3727  Abstract
153.
Strano S., Fontemaggi G., Costanzo A. et al. (2002) Journal of Biological Chemistry. 277, 21, p. 18817-18826  Abstract [All authors]
152.
Wang X., Michael D., De Murcia G. & Oren M. (2002) Journal of Biological Chemistry. 277, 18, p. 15697-15702  Abstract
151.
Folberg-Blum A., Sapir A., Shilo B. & Oren M. (2002) Oncogene. 21, 15, p. 2413-2417  Abstract
150.
Gottlieb T., Leal J., Seger R., Taya Y. & Oren M. (2002) Oncogene. 21, 8, p. 1299-1303  Abstract
149.
Michael D. & Oren M. (2002) Current opinion in genetics & development. 12, 1, p. 53-59  Abstract
148.
Courtois S., Verhaegh G., North S., Luciani M., Lassus P., Hibner U., Oren M. & Hainaut P. (2002) Oncogene. 21, 44, p. 6722-6728  Abstract

2001

147.
Susini L., Passer B., Amzallag-Elbaz N. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 26, p. 15067-15072  Abstract
[All authors]
146.
Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
Goetz A., van der Kuip d. K. H., Maya R., Oren M. & Aulitzky W. (2001) Cancer Research. 61, 20, p. 7635-7641  Abstract
145.
Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A. & Oren M. (2001) EMBO Journal. 20, 17, p. 4912-4922  Abstract
144.
Maya R., Balass M., Kim S. et al. (2001) GENES & DEVELOPMENT. 15, 9, p. 1067-1077  Abstract [All authors]
143.
Strano S., Munarriz E., Rossi M. et al. (2001) Journal of Biological Chemistry. 276, 18, p. 15164-15173  Abstract [All authors]
142.
Oren M. (2001) Experimental Cell Research. 264, 1, p. 1  Abstract
141.
The p53 saga: the good, the bad, and the dead.
Oren M. (2001) Harvey lectures. 97, p. 57-82  Abstract
140.
Sadot E., Geiger B., Oren M. & Ben-Ze'ev A. (2001) Molecular and Cellular Biology. 21, 20, p. 6768-6781  Abstract

2000

139.
Reinstein E., Scheffner M., Oren M., Ciechanover A. & Schwartz A. (2000) Oncogene. 19, 51, p. 5944-5950  Abstract
138.
Bar-Or R., Maya R., Segel L., Alon U., Levine A. & Oren M. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 21, p. 11250-11255  Abstract
137.
Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M. & McCormick F. (2000) Cell. 103, 2, p. 321-330  Abstract
136.
Strano S., Munarriz E., Rossi M. et al. (2000) Journal of Biological Chemistry. 275, 38, p. 29503-29512  Abstract [All authors]
135.
Maya R. & Oren M. (2000) Oncogene. 19, 28, p. 3213-3215  Abstract
134.
Amson R., Lassalle J., Halley H. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 10, p. 5346-5350  Abstract
[All authors]
133.
de Rozieres R. S., Maya R., Oren M. & Lozano G. (2000) Oncogene. 19, 13, p. 1691-1697  Abstract
132.
Blander G., Zalle N., Leal J., Bar-Or R., Yu C. & Oren M. (2000) FASEB Journal. 14, 14, p. 2138-2140  Abstract

1999

131.
Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y. & Shkedy D. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 26, p. 14973-14977  Abstract
130.
Oren M. (1999) Journal of Biological Chemistry. 274, 51, p. 36031-36034  Abstract
129.
Blander G., Kipnis J., Leal J., Yu C., Schellenberg G. & Oren M. (1999) Journal of Biological Chemistry. 274, 41, p. 29463-29469  Abstract
128.
Elkeles A. & Oren M. (1999) Molecular Medicine Today. 5, 8, p. 334-335  Abstract
127.
Roperch J., Lethrone F., Prieur S. et al. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 14, p. 8070-8073  Abstract
[All authors]
126.
Agami R., Blandino G., Oren M. & Shaul Y. (1999) Nature. 399, 6738, p. 809-812  Abstract
125.
Damalas A., Ben-Ze'ev A., Simcha I., Shtutman N., Leal J., Zhurinsky J., Geiger B. & Oren M. (1999) EMBO Journal. 18, 11, p. 3054-3063  Abstract
124.
Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments
Oren M. & Vousden K. (1999) Scientist. 13, 12, p. 11-11  Abstract
123.
Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999) Oncogene. 18, 21, p. 3205-3212  Abstract
122.
MDM2 suppresses p73 function without promoting p73 degradation
Zeng X., Chen L., Jost C. et al. (1999) Molecular and Cellular Biology. 19, 5, p. 3257-3266  Abstract [All authors]
121.
Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999) EMBO Journal. 18, 7, p. 1805-1814  Abstract
120.
Elkeles A., Juven-Gershon T., Israeli D., Wilder S., Zalcenstein A. & Oren M. (1999) Molecular and Cellular Biology. 19, 4, p. 2594-2600  Abstract
119.
Sionov R., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M. & Haupt Y. (1999) Journal of Biological Chemistry. 274, 13, p. 8371-8374  Abstract
118.
Juven-Gershon T. & Oren M. (1999) Molecular Medicine. 5, 2, p. 71-83  Abstract
117.
Blandino G., Levine A. & Oren M. (1999) Oncogene. 18, 2, p. 477-485  Abstract
116.
Oren M. & Rotter V. (1999) Cellular and Molecular Life Sciences. 55, 1, p. 9-11  Abstract

1998

115.
Muller M., Wilder S., Bannasch D. et al. (1998) Journal of Experimental Medicine. 188, 11, p. 2033-2045  Abstract [All authors]
114.
Wang Y., Blandino G., Oren M. & Givol D. (1998) Oncogene. 17, 15, p. 1923-1930  Abstract
113.
Gottlieb E. & Oren M. (1998) EMBO Journal. 17, 13, p. 3587-3596  Abstract
112.
Roperch J., Alvaro V., Prieur S. et al. (1998) Nature Medicine. 4, 7, p. 835-838  Abstract
[All authors]
111.
Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998) Molecular and Cellular Biology. 18, 7, p. 3974-3982  Abstract
110.
Yardley G., Zauberman A., Oren M. & Jackson P. (1998) FEBS Letters. 430, 3, p. 171-175  Abstract
109.
Ori A., Zauberman A., Doitsh G., Paran N., Oren M. & Shaul Y. (1998) EMBO Journal. 17, 2, p. 544-553  Abstract
108.
Oren M. (1998) Nature. 391, 6664, p. 233-234  Abstract
107.
Hosokawa K., Aharoni D., Dantes A. et al. (1998) Endocrinology. 139, 11, p. 4688-4700  Abstract
[All authors]

1997

106.
Gottlieb T. M. & Oren M. (1997) Seminars in Cancer Biology. 8, 5, p. 359-368  Abstract
105.
Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A. & Oren M. (1997) EMBO Journal. 16, 14, p. 4384-4392  Abstract
104.
Haupt Y., Maya R., Kazaz A. & Oren M. (1997) Nature. 387, 6630, p. 296-299  Abstract
103.
Ruaro E., Collavin L., DelSal G., Haffner R., Oren M., Levine A. & Schneider C. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 9, p. 4675-4680  Abstract
102.
Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. & Oren M. (1997) EMBO Journal. 16, 6, p. 1381-1390  Abstract
101.
Hansen R. & Oren M. (1997) Current opinion in genetics & development. 7, 1, p. 46-51  Abstract
100.
Friedman S., Shaulian E., Littlewood T., Resnitzky D. & Oren M. (1997) Oncogene. 15, 1, p. 63-70  Abstract
98.
Zauberman A., Oren M. & Zipori D. (1997) Oncogene. 15, 14, p. 1705-1711  Abstract
97.
Shaulian E., Resnitzky D., Shifman O., Blandino G., Amsterdam A., Yayon A. & Oren M. (1997) Oncogene. 15, 22, p. 2717-2725  Abstract

1996

96.
p53-mediated apoptosis: mechanisms and regulation.
Haupt Y. & Oren M. (1996) Behring Institute Mitteilungen. 97, p. 32-59  Abstract
95.
Nemani M., LinaresCruz G., BruzzoniGiovanelli H. et al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 17, p. 9039-9042  Abstract
[All authors]
94.
Bowman T., Symonds H., Gu L., Yin C., Oren M. & Van Dyke T. (1996) GENES & DEVELOPMENT. 10, 7, p. 826-835  Abstract
93.
Haupt Y., Barak Y. & Oren M. (1996) EMBO Journal. 15, 7, p. 1596-1606  Abstract
92.
Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells
Gottlieb E., Lindner S. & Oren M. (1996) Cell Growth and Differentiation. 7, 3, p. 301-310  Abstract
91.
Rowan S., Ludwig R., Haupt Y., Bates S., Lu X., Oren M. & Vousden K. (1996) EMBO Journal. 15, 4, p. 827-838  Abstract
90.
Tanaka N., Ishihara M., Lamphier M. et al. (1996) Nature. 382, 6594, p. 816-818  Abstract
[All authors]
89.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
[All authors]
88.
Eizenberg O., FaberElman A., Gottlieb E., Oren M., Rotter V. & Schwartz M. (1996) Molecular and Cellular Biology. 16, 9, p. 5178-5185  Abstract
87.
p53-Mediated apoptosis - Regulatory and mechanistic aspects
Haupt Y., Rowan S., Shaulian E., Gottlieb E., YonishRouach E., Vousden K. & Oren M. (1996) Cancer Genes: Functional Aspects. 7, p. 83-101  Abstract
86.
Oren M. & Prives C. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1288, 3, p. R13-R19  Abstract
85.
Friedlander P., Haupt Y., Prives C. & Oren M. (1996) Molecular and Cellular Biology. 16, 9, p. 4961-4971  Abstract
84.
Gottlieb T. M. & Oren M. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1287, 2-3, p. 77-102  Abstract

1995

83.
HIEBERT S., PACKHAM G., STROM D., HAFFNER R., Oren M., ZAMBETTI G. & CLEVELAND J. (1995) Molecular and Cellular Biology. 15, 12, p. 6864-6874  Abstract
82.
Cancer: The translation of advances in basic science to human therapy. 22-27 July, 1995 - La fondation des Treilles, Tourtour, France - Discussion
Harlow E., Tlsty T., Courtneidge S. et al. (1995) Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences. 318, 11, p. 1173-1179  Abstract
[All authors]
81.
Malcomson R. D., Oren M., Wyllie A. H. & Harrison D. J. (1995) British Journal of Cancer. 72, 4, p. 952-957  Abstract
80.
HAUPT Y., ROWAN S., SHAULIAN E., VOUSDEN K. & Oren M. (1995) GENES & DEVELOPMENT. 9, 17, p. 2170-2183  Abstract
79.
Zauberman A., FLUSBERG D., HAUPT Y., Barak Y. & Oren M. (1995) Nucleic Acids Research. 23, 14, p. 2584-2592  Abstract
78.
IDENTIFICATION OF P53 TARGET GENES THROUGH IMMUNE SELECTION OF GENOMIC DNA - THE CYCLIN-G GENE CONTAINS 2 DISTINCT P53 BINDING-SITES
Zauberman A., LUPO A. & Oren M. (1995) Oncogene. 10, 12, p. 2361-2366  Abstract
77.
AHARONI D., Dantes A., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 271-282  Abstract
76.
KERENTAL I., SUH B., Dantes A., LINDNER S., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 283-295  Abstract
75.
P53-MEDIATED APOPTOSIS IN HELA-CELLS CAN BE OVERCOME BY EXCESS PRB
HAUPT Y., ROWAN S. & Oren M. (1995) Oncogene. 10, 8, p. 1563-1571  Abstract
74.
EIZENBERG O., FABER-ELMAN A., GOTTLIEB E., Oren M., Rotter V. & Schwartz M. (1995) EMBO Journal. 14, 6, p. 1136-1144  Abstract
73.
Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma
Corvi R., Savelyeva L., Breit S., Wenzel A., Handgretinger R., Barak J., Oren M., Amler L. & Schwab M. (1995) Oncogene. 10, 6, p. 1081-1086  Abstract
72.
TRANSCRIPTIONAL REPRESSION BY THE C-TERMINAL DOMAIN OF P53
SHAULIAN E., HAVIV I., Shaul Y. & Oren M. (1995) Oncogene. 10, 4, p. 671-680  Abstract
71.
Haffner R. & Oren M. (1995) Current Opinion in Genetics and Development. 5, 1, p. 84-90  Abstract
70.
STUART E., HAFFNER R., Oren M. & GRUSS P. (1995) EMBO Journal. 14, 22, p. 5638-5645  Abstract

1994

69.
Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2
CIECHANOVER A., SHKEDY D., Oren M. & BERCOVICH B. (1994) Journal of Biological Chemistry. 269, 13, p. 9582-9589  Abstract
68.
GOTTLIEB E., HAFFNER R., VON RUDEN T., WAGNER E. & Oren M. (1994) EMBO Journal. 13, 6, p. 1368-1374  Abstract
67.
Relationship of p53 to the control of apoptotic cell death
Oren M. (1994) Seminars in Cancer Biology. 5, 3, p. 221-227  Abstract
66.
Barak Y., GOTTLIEB E., JUVENGERSHON T. & Oren M. (1994) GENES & DEVELOPMENT. 8, 15, p. 1739-1749  Abstract
65.
Barak Y., LUPO A., Zauberman A., JUVEN T., ALONIGRINSTEIN R., GOTTLIEB E., Rotter V. & Oren M. (1994) Cold Spring Harbor Symposia on Quantitative Biology. 59, p. 225-235  Abstract
64.
WILD-TYPE P(53) ACTIVITY CONTRIBUTES TO DEPENDENCE ON HEMATOPOIETIC SURVIVAL FACTORS
GOTTLIEB E., HAFFNER R., YONISHROUACH E., VONRUDEN T., WAGNER E. & Oren M. (1994) Apoptosis. 5, p. 31-45  Abstract

1993

63.
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
JUVEN T., Barak Y., Zauberman A., GEORGE D. & Oren M. (1993) Oncogene. 8, 12, p. 3411-3416  Abstract
62.
Levy N., YONISHROUACH E., Oren M. & Kimchi A. (1993) Molecular and Cellular Biology. 13, 12, p. 7942-7952  Abstract
61.
Telerman A., TUYNDER M., DUPRESSOIR T., ROBAYE B., SIGAUX F., SHAULIAN E., Oren M., ROMMELAERE J. & AMSON R. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 18, p. 8702-8706  Abstract
60.
Zauberman A., Barak Y., RAGIMOV N., Levy N. & Oren M. (1993) EMBO Journal. 12, 7, p. 2799-2808  Abstract
59.
SHAULIAN E., Zauberman A., MILNER J., DAVIES E. & Oren M. (1993) EMBO Journal. 12, 7, p. 2789-2797  Abstract
58.
ALONI, YOSEF - (1936-1993) - OBITUARY
Oren M. (1993) Oncogene. 8, 6, p. 1405-1405  Abstract
57.
Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif
RAGIMOV N., KRAUSKOPF A., NAVOT N., Rotter V., Oren M. & ALONI Y. (1993) Oncogene. 8, 5, p. 1183-1193  Abstract
56.
p53-mediated cell death: Relationship to cell cycle control
YONISHROUACH E., GRUNWALD D., Wilder S., Kimchi A., MAY E., LAWRENCE J., MAY P. & Oren M. (1993) Molecular and Cellular Biology. 13, 3, p. 1415-1423  Abstract
55.
Barak Y., JUVEN T., HAFFNER R. & Oren M. (1993) EMBO Journal. 12, 2, p. 461-468  Abstract
54.
MECHANISMS OF ACTION OF P53
BARAK Y., GINSBERG D., MICHAEL D., RAGIMOV N., SHAULIAN E., YONISHROUACH E., ZAUBERMAN A., ALONI Y. & OREN M. (1993) PHARMACOLOGY OF CELL DIFFERENTIATION. Rifkind RA.(eds.). p. 129-141 (trueINTERNATIONAL CONGRESS SERIES).  Abstract
53.
Yonish-Rouach E., Ginsberg D. & Oren M. (1993) Programmed Cell Death. p. 187-201  Abstract

1992

52.
Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding
SHAULIAN E., Zauberman A., GINSBERG D. & Oren M. (1992) Molecular and Cellular Biology. 12, 12, p. 5581-5592  Abstract
51.
The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
Yehiely F. & Oren M. (1992) Molecular Cancer Research. 3, 11, p. 803-809  Abstract
50.
p53: The ultimate tumor suppressor gene?
Oren M. (1992) FASEB Journal. 6, 13, p. 3169-3176  Abstract
49.
Oren M. (1992) Cancer and Metastasis Reviews. 11, 2, p. 141-148  Abstract
48.
Yaacov B. & Oren M. (1992) EMBO Journal. 11, 6, p. 2115-2121  Abstract

1991

47.
EIZENBERG O. & Oren M. (1991) Biochimica et Biophysica Acta - Gene Structure and Expression. 1129, 1, p. 34-42  Abstract
46.
Frequent p53 mutations in chemically induced murine fibrosarcoma
Halevy O., RODEL J., Peled A. & Oren M. (1991) Oncogene. 6, 9, p. 1593-1600  Abstract
45.
Michael D., YEHIELY F., GOTTLIEB E. & Oren M. (1991) Journal of Virology. 65, 8, p. 4160-4168  Abstract
44.
Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts
GINSBERG D., HIRAI S., PINHASIKIMHI O., Yaniv M. & Oren M. (1991) Oncogene. 6, 4, p. 669-672  Abstract
43.
Wild-type p53 can down-modulate the activity of various promoters
GINSBERG D., MECHTA F., Yaniv M. & Oren M. (1991) Proceedings of the National Academy of Sciences of the United States of America. 88, 22, p. 9979-9983  Abstract
42.
Ginsberg D., Michael D. & Oren M. (1991) Molecular and Cellular Biology. 11, 1, p. 582-585  Abstract
41.
MICHALOVITZ D., Halevy O. & Oren M. (1991) Journal of Cellular Biochemistry. 45, 1, p. 22-29  Abstract
40.
Yonish-Rouach E., Resnftzky D., Lotem J., Sachs L., Kimchi A. & Oren M. (1991) Nature. 352, 6333, p. 345-347  Abstract

1990

39.
Protein-binding elements in the promoter region of the mouse p53 gene
GINSBERG D., Oren M., Yaniv M. & PIETTE J. (1990) Oncogene. 5, 9, p. 1285-1290  Abstract
38.
MICHALOVITZ D., Halevy O. & Oren M. (1990) Cell. 62, 4, p. 671-680  Abstract
37.